Paul Collini - Concepedia

Author

Paul Collini

Also Known As

Andrew Drummond, Collini, P., Collini, Paul, Devesh J. Dhasmana, Jake Dunning, Jaydip Majumdar, Jenny Child, Jolanta Bernatoniene, Mount Sinai Health System COVID-19 Genomics Initiative, P Collini

122

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

University of Sheffield University of Nottingham University of Edinburgh University of Oxford Sheffield Teaching Hospitals NHS Foundation Trust

About

Paul Collini is an author at University of Sheffield specializing in medicine, covid-19, and viral immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.4K
2	Nursing	1	1	19
3	Public Health	1	1	19
4	Epidemiology	1	1	40
5	Family Medicine	1	1	19

Paul Collini

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization Drew Weissman, Mohamad‐Gabriel Alameh, Thushan I. de Silva, Cell Host & Microbe Viral EvolutionViral PathogenesisImmunologyD614g Spike MutationVirology	2020	351
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study Rishi K Gupta, Ewen M. Harrison, Antonia Ho, The Lancet Respiratory Medicine	2021	224
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty, The Lancet Respiratory Medicine	2021	192
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study Thomas M Drake, Aya Riad, Cameron J Fairfield, The Lancet	2021	161
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages Martin A. Bewley, Julie A. Preston, Mohammed Mohasin, American Journal of Respiratory and Critical Care Medicine	2017	96

Page 1